Search Results
Oct 27, 2025, 03:47 ET 138. Canton Fair zeigt praktische Ästhetik in Haus und Garten Innovation
Wurzelfäule zu verhindern und eine gleichmäßige Hydratation ohne manuelle Eingriffe zu gewährleisten. Ein weiteres Herzstück, der "unzerbrechliche" Jun-Porzellanblumentopf, verbindet traditionelle Keramikkunst mit moderner Polymertechnologie. Durch die Integration von recyceltem Meereskunststoff in seine Zusammensetzung
More news about: Canton Fair
Oct 27, 2025, 03:45 ET La 138e Canton Fair met en avant l'esthétique pratique dans l'innovation pour la maison et le jardin
racines et en garantissant une hydratation constante sans intervention manuelle. Une autre pièce maîtresse, le pot de fleurs "incassable" en porcelaine de Jun, associe l'art traditionnel de la céramique à la technologie moderne des polymères. En intégrant des plastiques marins recyclés dans sa composition,
More news about: Canton Fair
Oct 26, 2025, 20:15 ET 138th Canton Fair Showcases Practical Aesthetics in Home and Garden Innovation
regulate water automatically, preventing root rot and ensuring consistent hydration without manual intervention. Another centerpiece, the "unbreakable" Jun porcelain flowerpot, combines traditional ceramic artistry with modern polymer technology. By integrating recycled marine plastics into its composition,
More news about: Canton Fair
Oct 26, 2025, 20:15 ET 138th Canton Fair Showcases Practical Aesthetics in Home and Garden Innovation
regulate water automatically, preventing root rot and ensuring consistent hydration without manual intervention. Another centerpiece, the "unbreakable" Jun porcelain flowerpot, combines traditional ceramic artistry with modern polymer technology. By integrating recycled marine plastics into its composition,
More news about: Canton Fair
Oct 24, 2025, 18:32 ET Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies
employment and disability in patients with Sjogren's syndrome. Rheumatology (Oxford). 2009 Sep;48(9):1077-82. doi: 10.1093/rheumatology/kep141. Epub 2009 Jun 24. PMID: 19553376.11 ClinicalTrials.gov Identifier: NCT04951622. Available at:
More news about: Johnson & Johnson
Oct 24, 2025, 16:30 ET PINTEC Announces Changes in the Board of Directors
and dedicated service to PINTEC. Their leadership and insights have played an important role in shaping the Company's strategic direction." said Mr. Jun Dong, chairman of the Board. "At the same time, we are pleased to welcome Mr. Yang and Mr. Liu to the Board. We are confident that their appointments
More news about: Pintec Technology Holdings Limited
Oct 24, 2025, 12:14 ET Procedimentos estéticos injetáveis: quando é o momento certo para começar?
E. Estudo de autopercepção 1. Weiss RA et al. Dermatol Surg. 2016 Jun;42(6):699-709 2. Di Gregorio C et al. Clin Cosmet Investig Dermatol.
More news about: Galderma
Oct 24, 2025, 09:00 ET First Reliance Bancshares Reports Third Quarter 2025 Results
Jun 30
More news about: First Reliance Bancshares, Inc.
Oct 23, 2025, 16:15 ET Associated Banc-Corp Reports Third Quarter 2025 Net Income Available to Common Equity of $122 Million, or $0.73 per Common Share
Jun 30, 2025
More news about: Associated Banc-Corp
Oct 23, 2025, 16:05 ET Digital Realty Reports Third Quarter 2025 Results
30-Jun-25
More news about: Digital Realty Trust
Oct 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN
Cepton at more than double" the Koito Acquisition. The Amended Complaint further alleges that Cepton's Chief Executive Officer Defendant Jun Pei was subject to conflicts in his negotiations with Koito and encouraged the Board to recommend accepting the Koito Acquisition so as to protect his
More news about: Pomerantz LLP
Oct 23, 2025, 08:00 ET Verismo Therapeutics to Present at iMig 2025
Applications of Immunotherapy; Salon E Date/Time: Monday, October 27, 2025, 2:30 – 2:45 PM Presenter: Jun Xu, Ph.D., Executive Director of Translational Science, Verismo Therapeutics About
More news about: Verismo Therapeutics
Oct 23, 2025, 06:00 ET Dow reports third quarter 2025 results
Three Months Ended Jun 30
More news about: The Dow Chemical Company
Oct 22, 2025, 16:05 ET SouthState Bank Corporation Reports Third Quarter 2025 Results, Declares Quarterly Cash Dividend
Jun. 30,
More news about: SouthState Bank Corporation
Oct 22, 2025, 16:01 ET SEI Reports Third-Quarter 2025 Financial Results
Jun. 30
More news about: SEI Investments Company
Oct 22, 2025, 09:30 ET Jinxin Announces US$2 Million Share Repurchase Program
technologies that enhance user engagement and content experience, as well as digital content technologies that support our long-term growth," added Mr. Jun Jiang, Chief Operating Officer of Jinxin Technology Holding Company. "We remain focused on creating long-term shareholder value as we continue to strengthen
More news about: Jinxin Technology Holding Company
Oct 21, 2025, 16:30 ET Fulton Financial Corporation Announces 2025 Third Quarter Results
Jun 30
More news about: Fulton Financial Corporation
Oct 21, 2025, 09:00 ET Youth Innovation Safeguards Green Heritage: 2025 World Food Forum Youth Action on Green Agri-Heritage Held in Rome
goals. The subsequent International Youth Roundtable Dialogue, moderated by Ayesha Sabir, head of WFF Pakistan, brought together: Gong Jun, WFF Chengdu chapter lead; Sabin Lamichhane, head of WFF local action; Flora Igoe, head of WFF Culture, and youth representative from Laos and Mongolia.
More news about: China.org.cn
Oct 20, 2025, 16:30 ET Cadence Bank Announces Third Quarter 2025 Financial Results
Jun 2025
More news about: Cadence Bank
Oct 20, 2025, 16:05 ET Washington Trust Reports Third Quarter 2025 Results
Jun 30,2025
More news about: Washington Trust Bancorp, Inc.
Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
disease course: results from the Consortium of Rheumatology Researchers of North America registry. Arthritis Care Res (Hoboken). 2011 Jun;63(6):856-64. Sullivan E, Kershaw J, Blackburn S, Mahajan P, Boklage SH. Biologic Disease-Modifying Antirheumatic Drug Prescription
More news about: AbbVie
Oct 20, 2025, 07:00 ET CITY OF LONDON INVESTMENT GROUP PLC ("City of London" or "the Group" or "the Company" or "CLIG") TRADING UPDATE FOR THE QUARTER TO 30 SEPTEMBER 2025
Jun-25 Actual
More news about: City of London Investment Group PLC
Oct 20, 2025, 03:10 ET Day 2 of 2025 Sustainable Global Leaders Conference: Nobel Laureate Shares AI Insights, Major ESG Achievements Announced
Serbia, Former President of the United Nations General Assembly, and H.E. Salvador Moncada, Ambassador of Honduras to China. Liu Jun, President of Industrial and Commercial Bank of China and Wang Zhiheng, president of Agricultural Bank of China. Liu also held a dialogue with Michael
More news about: Sina
Oct 20, 2025, 02:44 ET ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma
locally advanced or metastatic urothelial carcinoma (RC48-C016) sponsored by RemeGen Co., Ltd. was presented at the Presidential Symposium by Professor Jun Guo from Beijing Cancer Hospital. It's the first time a research led by Chinese scholars in the field of urological oncology has ever been selected in
More news about: RemeGen Co., Ltd
Oct 19, 2025, 09:35 ET Max Stock Limited releases an immediate report on holdings of interested parties and senior officers as of September 30, 2025
previous report (30-Jun-2025)
More news about: Max Stock Limited